TAM
TFG Asset Management Portfolio holdings
AUM
$509M
1-Year Est. Return
24.47%
This Fund
S&P 500
1 Year Est. Return
+24.47%
AUM
$509M
AUM Growth
+$34.6M
(+7.3%)
Holding
38
Top Buys
| 1 | +$98.8M | |
| 2 | +$25.9M | |
| 3 | +$6.97M | |
| 4 |
SLNO
Soleno Therapeutics
SLNO
|
+$4M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
+$3.46M |
Top Sells
| 1 | +$4.46M | |
| 2 | +$4.17M | |
| 3 | +$3.71M | |
| 4 |
Praxis Precision Medicines
PRAX
|
+$2.17M |
| 5 |
Zevra Therapeutics
ZVRA
|
+$1.72M |
Sector Composition
| 1 | Technology | 63.41% |
| 2 | Healthcare | 24.23% |
| 3 | Energy | 7.37% |
| 4 | Communication Services | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
UiPath
PATH
$6.1B
| $280M | 54.98% |
25,207,628
+7,757,628
|
|
||
|
KGEI
2
Kolibri Global Energy
KGEI
$182M
| $37.5M | 7.37% |
6,834,504
-100,000
|
|
||
3
Warner Bros
WBD
$67.7B
| $25.4M | 4.98% |
+923,725
|
|
||
4
Workiva
WK
$2.79B
| $14.9M | 2.93% |
250,000
+100,000
|
|
||
5
Lyft
LYFT
$5.36B
| $13.3M | 2.61% |
1,000,000
|
|
||
6
Sprinklr
CXM
$1.39B
| $13.2M | 2.59% |
2,200,000
|
|
||
|
AUTL
7
Autolus Therapeutics
AUTL
$498M
| $13.1M | 2.58% |
9,500,000
|
|
||
8
Celldex Therapeutics
CLDX
$2.47B
| $9.91M | 1.95% |
312,316
+68,516
|
|
||
9
Arrowhead Research
ARWR
$11B
| $7.98M | 1.57% |
127,198
+30,263
|
|
||
10
Nektar Therapeutics
NKTR
$2.19B
| $7.41M | 1.46% |
103,037
+33,750
|
|
||
11
Annexon
ANNX
$888M
| $7.16M | 1.41% |
1,292,455
-740,000
|
|
||
12
Pharvaris
PHVS
$2.11B
| $6.26M | 1.23% |
221,611
+26,999
|
|
||
13
Alkermes
ALKS
$7.03B
| $5.65M | 1.11% |
159,791
+18,619
|
|
||
14
Agios Pharmaceuticals
AGIO
$1.75B
| $5.58M | 1.1% |
164,839
+2,821
|
|
||
15
Immunovant
IMVT
$6.84B
| $5.43M | 1.07% |
218,507
+52,320
|
|
||
|
16
Praxis Precision Medicines
PRAX
$9.76B
| $5.14M | 1.01% |
15,952
-7,000
|
|
||
17
Krystal Biotech
KRYS
$9.11B
| $5.08M | 1% |
19,668
+7,854
|
|
||
18
Dyne Therapeutics
DYN
$3.2B
| $4.68M | 0.92% |
258,132
+10,135
|
|
||
19
Amylyx Pharmaceuticals
AMLX
$1.6B
| $4.42M | 0.87% |
317,877
+45,049
|
|
||
|
MBX
20
MBX Biosciences
MBX
$1.5B
| $4.34M | 0.85% |
145,480
+2,153
|
|
||
|
DFTX
21
Definium Therapeutics
DFTX
$2.64B
| $3.78M | 0.74% |
+199,994
|
|
||
|
SLNO
22
DELISTED
Soleno Therapeutics
SLNO
| $3.42M | 0.67% |
+102,125
|
|
||
23
Axsome Therapeutics
AXSM
$12.1B
| $3.39M | 0.67% |
20,059
-6,875
|
|
||
24
Harmony Biosciences
HRMY
$1.83B
| $3.34M | 0.66% |
119,340
+36,516
|
|
||
|
SLN
25
Silence Therapeutics
SLN
$326M
| $3.32M | 0.65% |
630,161
+264,792
|
|